Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.7399
-0.0251 (-3.28%)
At close: Jun 9, 2026, 4:00 PM EDT
0.7000
-0.0399 (-5.39%)
Pre-market: Jun 10, 2026, 5:19 AM EDT
Valion Bio Market Cap
Valion Bio has a market cap or net worth of $2.32 million as of June 10, 2026. Its market cap has decreased by -37.49% in one year.
Market Cap
2.32M
Enterprise Value
12.14M
1-Year Change
-37.49%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since November 11, 2021, Valion Bio's market cap has decreased from $48.09M to $2.32M, a decrease of -95.17%. That is a compound annual growth rate of -48.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 2.40M | -34.43% |
| Dec 31, 2025 | 3.66M | 11.74% |
| Dec 31, 2024 | 3.28M | 24.20% |
| Dec 29, 2023 | 2.64M | -57.38% |
| Dec 30, 2022 | 6.19M | -83.57% |
| Dec 31, 2021 | 37.69M | -21.62% |
| Nov 11, 2021 | 48.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VivoSim Labs | 3.47M |
| Azitra | 3.42M |
| Adial Pharmaceuticals | 3.16M |
| GRI Bio | 2.89M |
| Oragenics | 2.68M |
| Calidi Biotherapeutics | 2.60M |
| Ensysce Biosciences | 2.36M |
| Bone Biologics | 2.24M |